Defining the Phenotype of Artemisinin-Resistant Malaria: A Modelling Approach
Lisa White and colleagues explore parasite clearance distributions in an area of artemisinin resistance with the aim of refining the phenotypic definition of resistance.
Vyšlo v časopise:
Defining the Phenotype of Artemisinin-Resistant Malaria: A Modelling Approach. PLoS Med 12(4): e32767. doi:10.1371/journal.pmed.1001823
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001823
Souhrn
Lisa White and colleagues explore parasite clearance distributions in an area of artemisinin resistance with the aim of refining the phenotypic definition of resistance.
Zdroje
1. Dondorp AM, Fairhurst RM, Slutsker L, Macarthur JR, Breman JG, Guerin PJ, et al. The threat of artemisinin-resistant malaria. N Engl J Med 2011; 365(12):1073–5. doi: 10.1056/NEJMp1108322 21992120
2. Leang R, Barrette A, Bouth DM, Menard D, Abdur R, Duong S, et al. Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010. Antimicrob Agents Chemother 2013; 57(2):818–26. doi: 10.1128/AAC.00686-12 23208711
3. Carrara VI, Lwin KM, Phyo AP, Ashley E, Wiladphaingern J, Sriprawat K, et al. Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999–2011: an observational study. PLoS Med 2013; 10(3):e1001398. doi: 10.1371/journal.pmed.1001398 23472056
4. Korenromp EL, Williams BG, Gouws E, Dye C, Snow RW. Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy. Lancet Infect Dis 2003; 3(6):349–58. 12781507
5. Miotto O, Almagro-Garcia J, Manske M, Macinnis B, Campino S, Rockett KA, et al. Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Nat Genet 2013; 45(6):648–55. doi: 10.1038/ng.2624 23624527
6. Witkowski B, Amaratunga C, Khim N, Sreng S, Chim P, Kim S, et al. Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies. Lancet Infect Dis 2013; 13(12):1043–9. doi: 10.1016/S1473-3099(13)70252-4 24035558
7. Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature 2013; 505, 50–55. doi: 10.1038/nature12876 24352242
8. Kamau E, Campino S, Amenga-Etego L, Drury E, Ishengoma D, Johnson K, et al. K13-propeller polymorphisms in Plasmodium falciparum parasites from sub-Saharan Africa. J Infect Dis 2014.
9. Taylor SM, Parobek CM, DeConti DK, Kayentao K, Coulibaly SO, Greenwood BM, et al. Absence of Putative Artemisinin Resistance Mutations Among Plasmodium falciparum in Sub-Saharan Africa: A Molecular Epidemiologic Study. J Infect Dis 2014.
10. Flegg JA, Guerin PJ, White NJ, Stepniewska K. Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator. Malar J 2011; 10:339. doi: 10.1186/1475-2875-10-339 22074219
11. Nkhoma SC, Stepniewska K, Nair S, Phyo AP, McGready R, Nosten F, et al. Genetic evaluation of the performance of malaria parasite clearance rate metrics. J Infect Dis 2013; 208(2):346–50. doi: 10.1093/infdis/jit165 23592863
12. Stepniewska K, Ashley E, Lee SJ, Anstey N, Barnes KI, Binh TQ, et al. In vivo parasitological measures of artemisinin susceptibility. J Infect Dis 2010; 201(4):570–9. doi: 10.1086/650301 20085495
13. Flegg JA, Guerin PJ, Nosten F, Ashley EA, Phyo AP, Dondorp AM, et al. Optimal sampling designs for estimation of Plasmodium falciparum clearance rates in patients treated with artemisinin derivatives. Malar J 2013; 12(1):411.
14. Jamsen KM, Duffull SB, Tarning J, Price RN, Simpson JA. A robust design for identification of the Parasite Clearance Estimator. Malar J 2013; 12(1):410.
15. White NJ. The parasite clearance curve. Malar J 2011; 10:278. doi: 10.1186/1475-2875-10-278 21939506
16. Anderson TJ, Nair S, Nkhoma S, Williams JT, Imwong M, Yi P, et al. High heritability of malaria parasite clearance rate indicates a genetic basis for artemisinin resistance in western Cambodia. J Infect Dis 2010; 201(9):1326–30. doi: 10.1086/651562 20350192
17. Takala-Harrison S, Clark TG, Jacob CG, Cummings MP, Miotto O, Dondorp AM, et al. Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia. Proceedings of the National Academy of Sciences of the United States of America. 2013; 110(1):240–5. doi: 10.1073/pnas.1211205110 23248304
18. Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet 2012; 379(9830):1960–6. doi: 10.1016/S0140-6736(12)60484-X 22484134
19. Amaratunga C, Sreng S, Suon S, Phelps ES, Stepniewska K, Lim P, et al. Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. Lancet Infect Dis 2012; 12(11):851–8. doi: 10.1016/S1473-3099(12)70181-0 22940027
20. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2009; 361(5):455–67. doi: 10.1056/NEJMoa0808859 19641202
21. Bethell D, Se Y, Lon C, Tyner S, Saunders D, Sriwichai S, et al. Artesunate dose escalation for the treatment of uncomplicated malaria in a region of reported artemisinin resistance: a randomized clinical trial. PLoS ONE. 2011; 6(5):e19283. doi: 10.1371/journal.pone.0019283 21603629
22. Benaglia T, Chauveau D, Hunter DR, Young DS. mixtools: An R Package for Analyzing Finite Mixture Models. J Stat Softw 2009; 32(6):1–29.
23. R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2011. doi: 10.1016/j.neuroimage.2011.01.013 21238596
24. Burnham KP, Anderson DR. Multimodel Inference Understanding AIC and BIC in Model Selection. Sociol Methods Res 2004; 33(2):261–304.
25. WHO. Emergency response to artemisinin resistance in the Greater Mekong subregion. Regional Framework for Action 2013–2015. 2013.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2015 Číslo 4
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- MUDr. Dana Vondráčková: Hepatopatie sú pri liečbe metamizolom väčším strašiakom ako agranulocytóza
- Vztah mezi statiny a rizikem vzniku nádorových onemocnění − metaanalýza
- Nech brouka žít… Ať žije astma!
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
Najčítanejšie v tomto čísle
- HIV Shedding from Male Circumcision Wounds in HIV-Infected Men: A Prospective Cohort Study
- A New Synthesis for Dual Use Research of Concern
- Research Priorities to Improve the Management of Acute Malnutrition in Infants Aged Less Than Six Months (MAMI)
- Defining the Phenotype of Artemisinin-Resistant Malaria: A Modelling Approach